Bain Capital joins Polaris to back cardiovascular treatment developer Cardurion in $300m deal

Bain Capital has made a $300m investment in Polaris-backed Cardurion Pharmaceuticals through Bain Capital Life Sciences and Bain Capital Private Equity.